1. Technical Field
The present disclosure relates generally to a non-invasive medical treatment apparatus. More particularly, the present disclosure relates to a vibrational therapy apparatus for delivering vibrational therapy and treating and preventing the onset of deep venous thrombosis (DVT).
2. Description of the Prior Art
Deep venous thrombosis (DVT) is the occlusion of a deep vein by a blood clot, i.e., thrombus. DVT generally affects the leg veins, such as, for example, the femoral vein or the popliteal vein, and occurs when the blood clot either partially blocks or completely blocks the flow of blood in the vein. A major risk associated with DVT is the development of pulmonary embolism, which occurs when a blood clot breaks loose from the walls of a vein and travels to the lungs, blocking the pulmonary artery or one of its branches.
Although there are several medical factors, such as injury, immobility and clotting disorders, which cause DVT other non-medical factors are also often culprits. For example, prolonged periods of sitting or lying, such as, for example, during an airline flight and a prolonged hospital stay which includes a prolonged period of immobility.
Various treatments have been developed to alleviate the effects of DVT. For example, intermittent pneumatic compression machines are used to improve blood circulation and prevent the formation of thrombi in the limbs of the patient. These devices typically include a pair of compression garments or sleeves which wrap around the patient's limbs, generally the legs. Each sleeve has a plurality of separate inflatable chambers which are connected via conduits to a source of compressed fluid, typically air. The chambers are sequentially inflated to provide a compressive pulse to the limb, thereby increasing blood circulation and minimizing the formation of thrombi. The compressive pulses begin around the portion of the limb farthest from the heart and progress sequentially towards the heart. For example, for a three-chambered leg sleeve, the ankle chamber is inflated first followed by the calf chamber, and then the thigh chamber. Typical compression devices are described in U.S. Pat. Nos. 4,013,069 and 6,610,021. Other methods of treatment for treating DVT include surgical procedures as well as medications, such as, anticoagulants.
However, because a patient may be susceptible to DVT and its effects with little or no warning, the best method against DVT and its effects is preventing the onset of DVT. For example, early and regular ambulation, i.e. walking, is a treatment that is recognized and recommended. Walking enhances blood flow by activating the body's muscle pumps, increasing venous velocity and preventing stasis. Nonetheless, walking is not a viable option for many people, such as elderly and/or infirm individuals. Moreover, walking is not always possible or safe, such as in an aircraft experiencing turbulence. Thus there is a need for a blood flow enhancement apparatus and method for enhancing blood flow to prevent the onset of DVT.
It is an aspect of the present disclosure to provide a vibrational therapy apparatus that delivers vibrational energy and may be used for treating and preventing the onset of DVT. It is a further object of the present disclosure to provide a vibrational therapy apparatus having a low profile vibrating plate system similar to the low profile vibrating plate system described in U.S. Utility patent application Ser. No. 11/369,467 filed on Mar. 7, 2006, the entire contents of which are incorporated herein by reference.
In accordance with the present disclosure, a vibrational therapy apparatus is provided capable of delivering vibrational energy for treating and preventing the onset of DVT. Other uses are also envisioned, such as treating postural instability. The vibrational therapy apparatus includes at least one platform member including at least one vibrating plate assembly for providing vibrational energy and at least one positioner. The at least one positioner is operatively associated with the at least one platform member for guiding patient tissue adjacent the at least one vibrating plate assembly.
Vibrational plate assembly can provide vibrational energy in at least two configurations of the at least one positioner. In a first configuration, the at least one positioner is substantially perpendicular to the at least one platform member. In a second configuration, the at least one positioner is in juxtaposed relation to the at least one platform member. Positioner is movable between the first configuration and the second configuration. In a first configuration, patient tissue contacts the at least one vibrating plate assembly, and in a second configuration, patient tissue does not contact the at least one vibrating plate assembly.
Vibrational therapy apparatus further includes at least one pad, positioned on the at least one platform member. The at least one pad is configured to contact patient tissue. Pad may be formed of memory foam material and may contact at least a portion of the at least one positioner. Pad may be removable from the apparatus and may be disposable.
Vibrational therapy apparatus further includes a control panel for controlling the operation of the at least one vibrating plate assembly.
In yet another embodiment of the present disclosure, a vibrational therapy assembly is provided which includes a first vibrational therapy apparatus having a first platform member including at least one vibrating plate assembly for providing vibrational energy and a first positioner operatively associated with the first platform member for guiding patient tissue adjacent the first platform member and a second vibrational therapy apparatus having a second platform member including at least one vibrating plate assembly for providing vibrational energy and a second positioner operatively associated with the second platform member for guiding patient tissue adjacent the first platform member and a means for removably connecting the first and second vibrational therapy apparatus. The means for removably connecting engages and disengages the first vibrational therapy apparatus from the second vibrational therapy apparatus.
The first vibrational therapy apparatus and the second vibrational therapy apparatus of the vibrational therapy assembly provide vibrational energy in at least two configurations of the first positioner and the second positioner. In a first configuration, the first and second platform members are parallel with respect to each other and the first and second positioners are substantially perpendicular to the first and second platform member. In a second configuration, the first and second platform members are parallel and with respect to each other and the first positioner and the second positioner are respectively in juxtaposed relation to the first platform member and the second platform member.
The foregoing features of the present disclosure will become more readily apparent and will be better understood by referring to the following detailed description of preferred embodiments, which are described hereinbelow with reference to the drawings wherein:
It is known to use vibrational treatment to treat conditions, such as postural instability, osteoporosis, etc., as described in U.S. Pat. Nos. 6,234,975; 6,561,991; and 6,607,497, the entire contents of which are incorporated herein by reference. The present disclosure provides for a vibrational therapy assembly and apparatus for providing vibrational treatment for treating and preventing the onset of deep venous thrombosis (DVT).
Preferred embodiments of the presently disclosed vibrational therapy assembly and apparatus will now be described in detail with reference to the drawing figures in which like reference numerals identify identical or corresponding elements.
With initial reference to
Positioner 18 is operatively associated with platform member 12. In
Positioner 18 may guide positioning of patient tissue adjacent to at least a portion of platform member 12, such as, for example, guiding or positioning of a patient tissue adjacent the vibrating plate assembly 100. Patient tissue, such as, for example, a leg and/or foot, is oriented such that vibrational energy generated by the vibrating plate assembly 100 is transferred to patient tissue. Patient tissue may receive vibration energy by direct contact with vibrating plate assembly 100. Patient tissue may also receive vibrational energy indirectly from vibration plate assembly 100, wherein vibrational energy is transferred through another portion of assembly 10b. For example, patient tissue may contact the positioner 18 or the pad 24 and vibrational energy is transferred from the vibrating plate assembly 100 through the positioner or the pad and to patient tissue.
Positioner 18 may lock in one or more angular positions relative to platform member 12. Hinge section may include a locking mechanism for locking positioner 18 into one or more of the angular positions relative to platform member 12.
The angular positions of the positioner 18 relative to the platform member 12 may be determined by the clinician, the type of medical therapy delivered to patient or the orientation of the patient receiving the vibrational therapy. Positioner 18, as shown in
In yet another embodiment of the present disclosure, pivoting mechanism may limit the angular movement of positioner 18, relative to the platform member 12, such that the angular condition of the positioner 18 in an open condition is optimal for a particular medical therapy. For example, for the treatment of DVT the pivoting mechanism may limit the angular movement of positioner 18, such that the maximum angular condition of the positioner 18 is substantially perpendicular to platform member 12.
Apparatus 10b may be repositioned or carried by grasping the handle 16 defined by the platform member 12.
Platform member 12 further includes at least one removable or fixed pad 24. Pad 24 supports the leg of a patient receiving vibrational treatment. The condition of pad 24 on platform member 12, relative to positioner 18, may be adjustable in order to provide proper support or positioning of the leg. Pad 24 may be placed against positioner 18 or spaced-apart from positioner 18.
Pad 24 may attach to platform member 12 to prevent movement during vibrational treatment. Various means of attachment may be used (i.e. velcro, snaps, buttons, clips, gel, adhesive or any combination thereof).
Apparatus 10b include at least one locating member 26 for locating the apparatus 10b during use. Locating member 26 may locate or position apparatus 10b relative to a structure, such as, for example, a bed, examination couch, patient stretch, patient trolley, patient recovery trolley, patient pallet, a chair, a wheelchair, an airline seat, a car seat, a bus seat, a sofa, a recliner, a scooter, etc.
Apparatus 10b may be positioned at the foot of a bed, or similar structure, with locating member 26 extending downward along the mattress at the foot of a bed thus preventing the apparatus 10b from moving toward the head of the bed during use. Similarly, locating member 26 may be positioned between the mattress and a bed's footboard thus securing the apparatus 10b to the foot of a bed.
Locating member 16 may position or secure apparatus 10b to a location approximate to a seat, such as a wheelchair, an airline seat, car seat, bus seat, recliner or scooter. For example, locating member 26 may be adapted to interface with a wheelchair footrest such that a patient sitting in a wheelchair may receive vibrational therapy. Locating member may be adapted to locate apparatus 10b in close proximity to patient's seat, such as a seat in an airplane, car or bus such that patient may receive vibrational therapy while traveling. Locating member 26 may be adapted to locate or position apparatus 10b relative to a sofa or recliner by extending into or under the sofa or recliner such that patient may receive vibrational therapy in the comfort of their home.
Locating member 26 may deploy from a first condition to a second condition. In the first condition, as illustrated in
It is further envisioned to integrate the apparatus 10 with structure, such as to integrate the apparatus 10 with a bed, examination couch, patient stretch, patient trolley, patient recovery trolley, patient pallet, a chair, a wheelchair, an airline seat, a car seat, a bus seat, a sofa, a recliner, a scooter, etc.
Vibrational therapy apparatus 10b includes a low profile vibrating plate assembly 100 similar in structure and operation as the low profile vibrating plate system disclosed and described in U.S. Utility application Ser. No. 11/369,467 filed on Mar. 7, 2006 and in U.S. Provisional Application filed on Jul. 11, 2006.
Platform member 12 includes a low profile vibrating plate assembly 100 adapted for transmitting vibrational energy, as described in detail hereinbelow. Platform member 12 may further include a control panel 22 for controlling the operation of the vibrating plate assembly 100. Control panel 22 may include a user interface for programming the apparatus 10. Control panel 22 can be removed from platform member 12 and configured to operate as a remote control device in operative communication with vibrating plate assembly 100. Control panel 22, configured to operate as a remote control device, communicates via wired or wireless means with the apparatus 10b.
Apparatus 10b can also be provided with touch sensitive technology for sensing when the patient's foot is positioned to receive vibrational therapy. Vibrating plate assembly 100 is activated or actuated when it senses that the patient's foot is positioned to receive vibrational therapy, i.e. placed over the vibrating plate assembly 100 or in contact therewith or with pad 24.
Apparatus 10b is preferably powered by at least one battery for enabling the apparatus 10b to be mobile. Apparatus 10b may also include a power cord for plugging the apparatus 10b to an electrical outlet, when feasible, for charging or conserving battery power.
Referring now to
Each vibrational apparatus 10a, 10b include a platform member 12a, 12b and a positioner 18a, 18b operatively associated with each respective platform member 12a, 12b. Positioner 18a, 18b and the respective platform member 12a, 12b may be hingedly attached along one side with pivot pin 20a, 20b. Other means of forming a pivotal connection may be used, such as, for example, a plurality of hinges, one or more ball and socket joints, one or more living hinges or other means of operatively associating two members as known in the art.
Platform members 12a, 12b may define handles 16a, 16b, and include control pads 22a, 22b and at least one vibrating plate assembly 100a, 100b. Handles 16a, 16b are disposed at respective sides of platform members 12a, 12b which are advantageously configured to enable one to grasp and transport the apparatus 10 when in the portable configuration as illustrated in
Locating members 26a (26b not shown) may be used to locate or position assembly 10 relative to a structure. Other configurations for the locating member 26a other than the configuration shown by the figures are envisioned. It is further envisioned to integrate the assembly 10 with structure, such as to integrate the assembly 10 with wheelchair, a bed, a chair, a scooter, patient pallet, examination couch, patient stretch, patient trolley, patient recovery trolley, etc.
Referring again to
Pad 24 may be reusable or may be used one or more times before being removable and disposed. Reusable pad may be used for several treatments prior to disposal or may be designed to be used for the life of the apparatus 10. Disposable pad may be used for a single treatment or may be used for two or more treatments before being discarded.
In yet another embodiment of the present disclosure, pad 24 may be formed of a moldable material such as foam, memory foam, clay, plaster, paste, gel, etc. In
With reference to
By varying the field intensity and/or alternating the polarity of the base magnets 106b a vertical vibration of platform 104 may be induced. The vibrational frequency is determined by the rate of change of the magnetic properties, while the amplitude of the vibration is determined by the magnetic field intensity. Additionally, the magnetic field intensity may be increased or decreased as needed, depending on a patient's weight, to properly condition and vibrate platform 104. In accordance with the present disclosure, a patient or user is permitted to stimulate and enhance blood flow in the limbs, in a manner described in detail hereinbelow.
When used, assembly 10 is first switched from a portable configuration, as illustrated in
As illustrated in
As shown in
As illustrated in
As illustrated in
In yet another embodiment of the present disclosure, positioner 18 includes at least one vibrational plate assembly, such as vibrating plate assembly 100, adapted to provide vibrational energy to patient tissue. In a closed configuration, vibrational plate assembly, of positioner, may deliver vibrational energy to patient tissue independent of the vibrational plate assembly 100 of platform member 12. For example, in the closed configuration, energy may be delivered from the vibrational plate assembly of positioner 18, and, in the open configuration, vibration energy may be delivered from the vibrational plate assembly 100 of platform member 12.
Alternatively, the first vibrational plate assembly 100 of platform member 12 and the vibrational plate assembly of positioner 18 may deliver vibrational energy simultaneously or may alternate delivery of vibrational energy.
The two or more vibrating plate assemblies may simultaneous deliver energy having the same frequency or may deliver vibrational energy having different frequencies.
Use of vibrational therapy assembly 10 is illustrated in
With reference to
With reference to
In yet another embodiment of the present disclosure, positioner can act as a platform or base for the apparatus for enabling the vibrating plates 100 to be positioned vertically with respect to the positioner. In this configuration, a user is able to rest his legs within the removable pads 24 while seated.
With reference to
It is envisioned to provide a processor, with memory capable of executing a set of instruction stored in the processor's memory, for enabling the apparatus 10a, 10b to be programmable via either by the user through the user interface on the control pad 22a, 22b or by a remote connection via communications circuitry provided within the apparatus 10a, 10b and in operative communication with the processor as described in a U.S. patent application filed on Jul. 17, 2006 titled “Dynamic Motion Therapy Apparatus Having a Treatment Feedback Indicator” , the entire contents of which are incorporated herein by reference. The processor can be programmed to sound an alarm when a treatment session should be started and to automatically shut-off the vibrating plate assembly 100a, 100b when the treatment time has lapsed. A memory within the processor can store patient treatment-related data and other information, such as name of patient, age, prescription medications being taken by patient, etc. The treatment related data can be transmitted to a remote monitoring station as described in a U.S. patent application filed on Jul. 17, 2006 titled “Dynamic Motion Therapy Apparatus Having a Treatment Feedback Indicator”,
While several embodiments of the disclosure have been shown in the drawings and/or discussed herein, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
The present application claims priority to a U.S. Provisional Application filed on Jul. 18, 2005 and assigned U.S. Provisional Application Ser. No. 60/700,092, now abandoned; the entire contents of the provisional application are incorporated herein by reference. The entire contents of U.S. Provisional Application filed on Jul. 11, 2006 titled “System and Method for a Low Profile Vibrating Plate”, now abandoned, are incorporated herein by reference. The present application is also a Continuation-In-Part patent application of a U.S. patent application filed on Mar. 7, 2006 titled “System and Method for a Low Profile Vibrating Plate” and assigned U.S. patent application Ser. No. 11/369,467, now abandoned; the entire contents of which are incorporated herein by reference. U.S. patent application Ser. No. 11/369,467 claims priority from U.S. Provisional Application filed on Mar. 7, 2005, titled “System and Method for a Low Profile Vibrating Plate” and assigned U.S. Provisional Application Ser. No. 60/659,216, now abandoned; the entire contents of which are incorporated herein by reference. The entire contents of currently pending U.S. patent application filed on Jul. 17, 2006 titled “Dynamic Motion Therapy Apparatus Having a Treatment Feedback Indicator”, are incorporated herein by reference. U.S. patent application filed on Jul. 17, 2006, titled “Dynamic Motion Therapy Apparatus Having a Treatment Feedback Indicator” claims priority from U.S. patent application filed on Mar. 6, 2006 titled “Supplemental Support Structures Adapted to Receive a Non-invasive Dynamic Motion Therapy Device” and assigned U.S. patent application Ser. No. 11/369,611, now abandoned; the contents of which are hereby incorporated by reference. U.S. patent application Ser. No. 11/369,611 claims priority from a U.S. Provisional Application filed on Mar. 7, 2005 and assigned U.S. Provisional Application No. 60/659,159, now abandoned; the contents of which are hereby incorporated by reference. The U.S. patent application filed on Jul. 17, 2006 is also a Continuation-In-Part patent application of a U.S. patent application filed on Mar. 24, 2006 titled “Apparatus and Method for Monitoring and Controlling the Transmissibility of Mechanical Vibration Energy During Dynamic Motion Therapy” and assigned U.S. patent application Ser. No. 11/388,286, now abandoned; the contents of which are hereby incorporated by reference. U.S. patent application Ser. No. 11/388,286 claims priority from a U.S. Provisional Application filed on Mar. 24, 2005 and assigned U.S. Provisional Application No. 60/665,013, now abandoned; the contents of which are hereby incorporated by reference. The U.S. patent application filed on Jul. 17, 2006 further claims the benefit of and priority to U.S. Provisional Application filed on Jul. 27, 2005 titled “Method and Apparatus for Monitoring Patient Compliance During Dynamic Motion Therapy” and assigned U.S. Provisional Application Ser. No. 60/702,815, now abandoned; the contents of which are hereby incorporated by reference. Additionally, the U.S. patent application filed on Jul. 17, 2006 claims the benefit of and priority to U.S. Provisional Application filed on Jul. 27, 2005 titled “Dynamic Motion Therapy Apparatus Having a Treatment Feedback Indicator” and assigned U.S. Provisional Application Ser. No. 60/702,735, now abandoned; the contents of which are hereby incorporated by reference. The present application is also related to U.S. Pat. Nos. 6,234,975; 6,561,991; and 6,607,497, the entire contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1125931 | Arnest | Jan 1915 | A |
1945675 | Binney | Feb 1934 | A |
2193978 | Miller | Mar 1940 | A |
2345439 | Tompkins | Mar 1944 | A |
2779328 | Grossi | Jan 1957 | A |
2845063 | Charles | Jul 1958 | A |
2902993 | Wagner | Sep 1959 | A |
2916745 | Lesk et al. | Dec 1959 | A |
3134451 | Hanssen | May 1964 | A |
3193034 | Hutchinson et al. | Jul 1965 | A |
3304036 | Davis | Feb 1967 | A |
3304449 | Pohlman et al. | Feb 1967 | A |
3499437 | Balamuth | Mar 1970 | A |
3581739 | Brandt et al. | Jun 1971 | A |
3593239 | Hofman | Jul 1971 | A |
3760799 | Crowson | Sep 1973 | A |
3762402 | Abramovitz | Oct 1973 | A |
3765407 | Prince | Oct 1973 | A |
3767195 | Dimick | Oct 1973 | A |
3841320 | Brown | Oct 1974 | A |
3890953 | Kraus et al. | Jun 1975 | A |
3911907 | Smith, Jr. | Oct 1975 | A |
3961380 | Garr | Jun 1976 | A |
4013069 | Hasty | Mar 1977 | A |
4105017 | Ryaby et al. | Aug 1978 | A |
4232661 | Christensen | Nov 1980 | A |
4266532 | Ryaby et al. | May 1981 | A |
4266533 | Ryaby et al. | May 1981 | A |
4315503 | Ryaby et al. | Feb 1982 | A |
4326506 | Kawabata | Apr 1982 | A |
4358105 | Sweeney, Jr. | Nov 1982 | A |
4369537 | Midgley | Jan 1983 | A |
4381040 | Brouwer | Apr 1983 | A |
D269305 | Nakao et al. | Jun 1983 | S |
4446586 | Reed et al. | May 1984 | A |
4452326 | Hanssen et al. | Jun 1984 | A |
4530360 | Duarte | Jul 1985 | A |
4570927 | Petrofsky et al. | Feb 1986 | A |
4669483 | Hepp et al. | Jun 1987 | A |
4687195 | Potts | Aug 1987 | A |
4697581 | Endo et al. | Oct 1987 | A |
4710655 | Masaki | Dec 1987 | A |
4750574 | Williams | Jun 1988 | A |
4782822 | Ricken | Nov 1988 | A |
4787888 | Fox | Nov 1988 | A |
4788968 | Rudashevsky et al. | Dec 1988 | A |
D299787 | Bates | Feb 1989 | S |
4836316 | Carnevale et al. | Jun 1989 | A |
4858599 | Halpern | Aug 1989 | A |
4890953 | Malatesta | Jan 1990 | A |
4905671 | Senge et al. | Mar 1990 | A |
4913248 | Zakai | Apr 1990 | A |
4917376 | Lo | Apr 1990 | A |
4927138 | Ferrari | May 1990 | A |
4928959 | Bassett et al. | May 1990 | A |
4986534 | Meier et al. | Jan 1991 | A |
5000442 | Dalebout et al. | Mar 1991 | A |
5003965 | Talish et al. | Apr 1991 | A |
5046484 | Bassett et al. | Sep 1991 | A |
5103806 | McLeod et al. | Apr 1992 | A |
5107540 | Mooney et al. | Apr 1992 | A |
5108452 | Fallin et al. | Apr 1992 | A |
5113850 | Larremore et al. | May 1992 | A |
5133420 | Smith | Jul 1992 | A |
5145027 | Petzl et al. | Sep 1992 | A |
5186162 | Talish et al. | Feb 1993 | A |
5188095 | Healy | Feb 1993 | A |
5191880 | McLeod et al. | Mar 1993 | A |
5211160 | Talish et al. | May 1993 | A |
5255957 | Opsvik et al. | Oct 1993 | A |
5273028 | McLeod et al. | Dec 1993 | A |
5273502 | Kelsey et al. | Dec 1993 | A |
5295931 | Dreibelbis et al. | Mar 1994 | A |
5318561 | McLeod et al. | Jun 1994 | A |
RE34663 | Seale | Jul 1994 | E |
5335188 | Brisson | Aug 1994 | A |
5336144 | Rodden | Aug 1994 | A |
5337757 | Jain et al. | Aug 1994 | A |
5339804 | Kemp | Aug 1994 | A |
5351389 | Erickson et al. | Oct 1994 | A |
5368044 | Cain et al. | Nov 1994 | A |
5376065 | McLeod et al. | Dec 1994 | A |
5380269 | Urso | Jan 1995 | A |
5409446 | Rattner | Apr 1995 | A |
RE34959 | Potts | May 1995 | E |
5429585 | Liang | Jul 1995 | A |
5431612 | Holden | Jul 1995 | A |
5437668 | Aronson et al. | Aug 1995 | A |
5466215 | Lair et al. | Nov 1995 | A |
5468220 | Sucher | Nov 1995 | A |
5478306 | Stoner | Dec 1995 | A |
5484388 | Bassett et al. | Jan 1996 | A |
5492525 | Gibney | Feb 1996 | A |
5496256 | Bock et al. | Mar 1996 | A |
5501657 | Feero | Mar 1996 | A |
5520612 | Winder et al. | May 1996 | A |
5520614 | McNamara et al. | May 1996 | A |
5538489 | Magid | Jul 1996 | A |
5556372 | Talish et al. | Sep 1996 | A |
5578060 | Pohl et al. | Nov 1996 | A |
5602432 | Mizutani | Feb 1997 | A |
5626554 | Ryaby et al. | May 1997 | A |
5702353 | Guzzini et al. | Dec 1997 | A |
5708236 | Shaanan et al. | Jan 1998 | A |
5716331 | Chang | Feb 1998 | A |
5721400 | Haraldsson et al. | Feb 1998 | A |
5730705 | Talish et al. | Mar 1998 | A |
5741317 | Ostrow | Apr 1998 | A |
5755746 | Lifshey et al. | May 1998 | A |
5762616 | Talish | Jun 1998 | A |
5779600 | Pape | Jul 1998 | A |
5797860 | Moriyasu | Aug 1998 | A |
5868649 | Erickson et al. | Feb 1999 | A |
5871446 | Wilk | Feb 1999 | A |
5886302 | Germanton et al. | Mar 1999 | A |
5904659 | Duarte et al. | May 1999 | A |
5910123 | Wang | Jun 1999 | A |
5913838 | Reilly | Jun 1999 | A |
5957814 | Eschenbach | Sep 1999 | A |
5971984 | Taylor et al. | Oct 1999 | A |
5987982 | Wenman et al. | Nov 1999 | A |
5997490 | McLeod et al. | Dec 1999 | A |
6019710 | Dalebout et al. | Feb 2000 | A |
6022349 | McLeod et al. | Feb 2000 | A |
D421828 | Malka | Mar 2000 | S |
6050364 | Popall et al. | Apr 2000 | A |
6061597 | Rieman et al. | May 2000 | A |
6063046 | Allum | May 2000 | A |
6068596 | Weth et al. | May 2000 | A |
6080088 | Petersen et al. | Jun 2000 | A |
6086078 | Ferez | Jul 2000 | A |
6093135 | Huang | Jul 2000 | A |
6106491 | Gianutsos | Aug 2000 | A |
6116691 | Reece | Sep 2000 | A |
6119291 | Osborne et al. | Sep 2000 | A |
6179797 | Brotz | Jan 2001 | B1 |
6234975 | McLeod et al. | May 2001 | B1 |
6258020 | Lopez | Jul 2001 | B1 |
6346088 | Stone et al. | Feb 2002 | B1 |
6421935 | Bartlett | Jul 2002 | B1 |
6440046 | Tholkes | Aug 2002 | B1 |
D467407 | Berg et al. | Dec 2002 | S |
D471346 | Bray, Jr. et al. | Mar 2003 | S |
6558304 | Bardon et al. | May 2003 | B1 |
6561991 | McLeod et al. | May 2003 | B2 |
6607497 | McLeod et al. | Aug 2003 | B2 |
6610021 | Bock | Aug 2003 | B1 |
6620117 | Johnson et al. | Sep 2003 | B1 |
6632158 | Nashner | Oct 2003 | B1 |
6656137 | Tyldsley et al. | Dec 2003 | B1 |
6843776 | Trandafir et al. | Jan 2005 | B2 |
6884227 | Krompasick | Apr 2005 | B2 |
6902320 | McKenna | Jun 2005 | B2 |
20010000782 | Schiessl | May 2001 | A1 |
20020077570 | McLeod et al. | Jun 2002 | A1 |
20020183662 | Lu et al. | Dec 2002 | A1 |
20030083599 | Kitov | May 2003 | A1 |
20030090374 | Quigley | May 2003 | A1 |
20040059331 | Mullaney | Mar 2004 | A1 |
20040067833 | Talish et al. | Apr 2004 | A1 |
20040068211 | Leivseth et al. | Apr 2004 | A1 |
20040092848 | Trandafir et al. | May 2004 | A1 |
20040092849 | Talish | May 2004 | A1 |
20040260211 | Maalouf | Dec 2004 | A1 |
20050026750 | Oglesby et al. | Feb 2005 | A1 |
20050131319 | der Meer | Jun 2005 | A1 |
20050148911 | Talish et al. | Jul 2005 | A1 |
20050154334 | Trandafir et al. | Jul 2005 | A1 |
20060047230 | Talish | Mar 2006 | A1 |
Number | Date | Country |
---|---|---|
4393393 | Dec 1993 | AU |
2136012 | Dec 1993 | CA |
323767 | Aug 1957 | CH |
1566521 | Mar 1971 | DE |
3227519 | Feb 1983 | DE |
9410902 | Nov 1995 | DE |
196 39 477 | Apr 1998 | DE |
10201255 | Jul 2003 | DE |
0029298 | May 1981 | EP |
0695559 | Feb 1996 | EP |
1026484 | Aug 2000 | EP |
0642331 | Jan 2001 | EP |
1 400 264 | Mar 2004 | EP |
2 562 446 | Oct 1985 | FR |
60150749 | Aug 1985 | JP |
62-72359 | Apr 1987 | JP |
2-60608 | Mar 1990 | JP |
U 2-32830 | Mar 1990 | JP |
U 4-3736 | Jan 1992 | JP |
5317376 | Dec 1993 | JP |
7507224 | Aug 1995 | JP |
3036291 | Jan 1997 | JP |
3038101 | Jun 1997 | JP |
11319144 | Nov 1999 | JP |
2000-60978 | Feb 2000 | JP |
3069745 | Apr 2000 | JP |
2001 000496 | Jan 2001 | JP |
2001-017493 | Jan 2001 | JP |
2001 070383 | Mar 2001 | JP |
2001-513352 | Sep 2001 | JP |
2001-517134 | Oct 2001 | JP |
2001 346846 | Dec 2001 | JP |
2002-153349 | May 2002 | JP |
2002-306559 | Oct 2002 | JP |
2002-325808 | Nov 2002 | JP |
2003-102801 | Apr 2003 | JP |
3547742 | Apr 2004 | JP |
2004-321665 | Nov 2004 | JP |
2004-337275 | Dec 2004 | JP |
2005-512721 | May 2005 | JP |
0225300 | Jul 1999 | KR |
183314 | Nov 1996 | MX |
584842 | Dec 1977 | SU |
WO 9324092 | Dec 1993 | WO |
WO 9521580 | Aug 1995 | WO |
WO 9603104 | Feb 1996 | WO |
WO 02053084 | Jul 2002 | WO |
WO 03030805 | Apr 2003 | WO |
WO 03055389 | Jul 2003 | WO |
WO 2004043324 | May 2004 | WO |
WO 2004096108 | Nov 2004 | WO |
WO 2004103244 | Dec 2004 | WO |
WO 2005000188 | Jan 2005 | WO |
Entry |
---|
PCT International Search Report dated Oct. 30, 2006 for PCT/US2006/027723 filed Jul. 18, 2006. |
Edward, V., PCT International Search Report (ISR) for PCT/US2006/008132. Jul. 2, 2006, European Patent Office. |
Knoflacher, N., PCT International Search Report (ISR) for PCT/US2007/015732. Jan. 24, 2008, European Patent Office. |
Knoflacher, N., PCT International Search Report (ISR) and Written Opinion for PCT/US2007/015694. Dec. 12, 2007, European Patent Office. |
Artikis, T., PCT International Search Report (ISR) for PCT/US2006/010753. Jul. 20, 2006, European Patent Office. |
Fischer, E., PCT International Search Report (ISR) for PCT/US2006/007983. Jul. 13, 2006, European Patent Office. |
Yu, J., International Preliminary Report on Patentability (IPRP) for PCT/US06/07983. Apr. 20, 2007, Alexandria, VA. |
Fischer, E., PCT International Search Report (ISR) for PCT/US2006/027355. Oct. 26, 2006, European Patent Office. |
Fischer, E., PCT International Search Report (ISR) for PCT/US2006/027832. Oct. 26, 2006, European Patent Office. |
Pope, M.H. et al., “Mounting of the Transducers in Measurement of Segmental Motion of the Spine,” J. Biomechanics, 1986, pp. 675-677, vol. 19, No. 8. |
Holmlund et al., “Mechanical impedance of the human body in vertical direction,” Applied Ergonomics, Elsevier Science Ltd. (2000). |
Wei et al., “The prediction of seat transmissibility from measures of seat impedance,” Journal of Sound and Vibration, 214(1), pp. 121-137 (1998). |
Jordan, J., “Good Vibrations and Strong Bones,” Am. J. Physiol. Reful. Integr. Comp. Physiol., 288 (3): R555-556 (2005). |
Stewart, J.M. et al., “Plantar vibration improved leg fluid . . . ,” The American Journal of Phgy—Reg, Integ and Comp Phgy, Oct. 7, 2004, 288:R623-R629, New York, NY. |
Walsh, W.R. et al., “Influence of Dynamic Motion Therapy on bone ingrowth into a bone graft substitute”, Surg. & Ortho. Res. Labs., Univ. of New S. Wales, w.walsh@unsw.edu.au. |
Bassett, C. Andrew L. and Robert O. Becker, “Generation of Electric Potentials by Bone in Response to Mechanical Stress,” Science Magazine, 137, pp. 1063-1064 (1962). |
El Haj, A.J., Skerry, T.M., Caterson, B., Lanyon, L.E., “Protoglycans in Bone Tissue: Identification, and Possible Function in Strain-related Bone Remodeling,” presented at the 34th Annual Meeting, ORS (Feb. 1988). |
Skerry, T.M., Pead, M.J., Suswillo, R., Vedi, S., Lanyon, L.E., “Strain-related Remodeling in Bone Tissue: Early Stages of the Cellular Response to Bone Loading In Vivo,” presented at the 34th Annual Meeting, ORS (Feb. 1988). |
Fritton, S.P., Hart, R.T., “Simulation of In Vivo Trabecular Bone Adaptation,” presented at 41st Annual meeting of the Orthopaedic Research Society, Orlando, Florida Feb. 13-16, 1995. |
McLeod, K.J., “Effects of Low Level Vibration on Muscle Activity and Blood Flow,” presented at 3rd Meeting of the Micromechanical Tissue Repair Society (MTR), San Diego, California (2002). |
Goodship, A., “The Implications of Micromotion on Bone Repair and Tissue Differentiation,” presented at 3rd Meeting of the Micromechanical Tissue Repair Society (MTR), San Diego California (2002). |
Madhavan, G., Villanueva, Jr. A., McLeod, K.J., “Frequency Dependent Response of the Cardio-Vascular System to Foot Based Vibration While in the Seated Position,” presented at the Biomedical Engineering Society Annual Meeting (2002). |
Villanueva, Jr. A., Madhavan, G., McLeod, K.J., “Changes in the Non-Linear Dynamics of Heart Rate Variability Due to Foot Based Vibration While in the Seated Position,” presented at the Biomedical Engineering Society Annual Meeting (2002). |
McLeod, K.J., Ryaby, J.P., McCabe, J.M., “The Role of Postural Sway in the Maintenance of Bone Mass,” poster presentation, ASBMR, 24th Annual Meeting, San Antonio, Texas (Sep. 2002). |
Madhavan, G., McLeod, K.J., “Effect of Plantar Stimulation on Heart Rate Variability Under Orthostatically Stressed Conditions,” Biomedical Engineering Society Annual Meeting (2003). |
McLeod, K.J., Ryaby, J.P., “Bone Mass and Skeletal Muscle Pump Activity in Elderly Persons,” poster presentation, 1st Joint Meeting of the Int'l Bone and Mineral Society (IBMS) and the Japanese Society of Bone and Mineral Research (JSBMR), Osaka, Japan (Jun. 2003). |
McLeod, K.J., Lee, D., Davenport, D., “Bone Mineral Density and Orthostatic Intolerance in the Perimenopausal Population,” poster presentation, 1st Joint Meeting of the Int'l Bone and Mineral Society (IBMS) and the Japanese Society of Bone and Mineral Research (JSBMR), Osaka, Japan (Jun. 2003). |
McLeod, K.J., McCabe, J., and Ryaby, J.P., “The Role of Postural Sway in the Maintenance of Bone Mass,” submitted to J. Gerontology (Jan. 2004). |
McLeod, K.J., Spathis, R., “Vascular Pressure in the Lower Limbs and Bone Mineral Density,” submitted to the Am. Society for Bone and Mineral Research (2004). |
McLeod, K.J., Stewart, J.M, “Lymphatic Flow and Bone Mineral Density,” presented at ASBMR (2004). |
Midura, R.J., Dillman, C.J., Grabiner, M.D., “Low amplitude, high frequency strains imposed by electrically stimulated skeletal muscle retards the development of osteopenia in the hindlimb of suspended rats,” Med. Eng. & Phys., 27 (2005) 285-293. |
Madhavan G, Stewart JM, McLeod KJ, “Effect of Plantar Micromechanical Stimulation on Cardiovascular[. . . ],” Am. J. Phys. Med. Rehabil., 2005, vol. 84, No. 5, 338-345. |
Frankel, V.H and McLeod, K.J., “Calf Muscle Stimulation as an Adjunct to Orthopaedic Surgery,” manuscript submitted for publication (submitted Apr. 2005). |
Number | Date | Country | |
---|---|---|---|
20070038165 A1 | Feb 2007 | US |
Number | Date | Country | |
---|---|---|---|
60700092 | Jul 2005 | US | |
60702735 | Jul 2005 | US | |
60702815 | Jul 2005 | US | |
60665013 | Mar 2005 | US | |
60659216 | Mar 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11369467 | Mar 2006 | US |
Child | 11488227 | US | |
Parent | 11388286 | Mar 2006 | US |
Child | 11369467 | US |